CID 16077843

2-[3-[4-[[2-[1-(4-tert-butyl-2-chloro-phenyl)tetrazol-5-yl]sulfanylacetyl]amino]-3-chloro-phenyl]-1,1-dimethyl-prop-2-ynoxy]-n-(4-hydroxyphenyl)acetamide

Structural Information

Molecular Formula
C32H32Cl2N6O4S
SMILES
CC(C)(C)C1=CC(=C(C=C1)N2C(=NN=N2)SCC(=O)NC3=C(C=C(C=C3)C#CC(C)(C)OCC(=O)NC4=CC=C(C=C4)O)Cl)Cl
InChI
InChI=1S/C32H32Cl2N6O4S/c1-31(2,3)21-7-13-27(25(34)17-21)40-30(37-38-39-40)45-19-29(43)36-26-12-6-20(16-24(26)33)14-15-32(4,5)44-18-28(42)35-22-8-10-23(41)11-9-22/h6-13,16-17,41H,18-19H2,1-5H3,(H,35,42)(H,36,43)
InChIKey
WFTNJTXZLDKMNO-UHFFFAOYSA-N
Compound name
2-[4-[4-[[2-[1-(4-tert-butyl-2-chlorophenyl)tetrazol-5-yl]sulfanylacetyl]amino]-3-chlorophenyl]-2-methylbut-3-yn-2-yl]oxy-N-(4-hydroxyphenyl)acetamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

666.15826 Da
Monoisotopic Mass

7.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 667.16554 259.9
[M+Na]+ 689.14748 266.0
[M-H]- 665.15098 262.3
[M+NH4]+ 684.19208 256.4
[M+K]+ 705.12142 257.8
[M+H-H2O]+ 649.15552 242.9
[M+HCOO]- 711.15646 254.1
[M+CH3COO]- 725.17211 265.0
[M+Na-2H]- 687.13293 254.6
[M]+ 666.15771 260.7
[M]- 666.15881 260.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.